August 2009
We are pleased to announce that our long time advisor Tristone Partners has been voted the 2009 UK Niche Energy Advisory Firm of the Year... ACQ Finance Magazine in house panel and close to 2800 in...
Press release, 24 March 2009
Bonesupport gains its second EU product approval The medical technology company Bonesupport has received EU approval for Cerament™ Bone Void Filler. The product is a ceramic bone substitute pri...
February 2009
Vencorp is pleased to co-sponsor the 8th MedTech Investing Europe Conference, 12th February & 13th February, 2009 in EPFL Lausanne, Switzerland. MTI Europe is the leading European event for bringing ...
Press release, 10 November 2008
Injectable bone substitute receives EU approval for treatment of vertebral fractures Cerament™ Spine Support, key product of medical technology company Bonesupport, has received EU approval for...
September 2008
BONESUPPORT acquires Ultrazonix and implements SEK 122 million ($20 mill; €13 mill) new share issue The medical device company Bonesupport has acquired Ultrazonix, a medical technology company whic...
February 2008
Following a long tradition of friendship and partnership with Russia, Vencorp Partners was for the fourth time in a row one of the sponsor of the chess Moscow Aeroflot Open. The tournament reached a...
June 2007
Vencorp Partners has lead a B recap funding round in MKL System SAS, a leading French video analytics software company which focuses on providing unique digital video and still picture analysis soluti...
February 2007
Vencorp Partners is pleased to communicate that for the third year in a row, Vencorp was one of the sponsor contributing to the success of one the major chess events in Russia: the Moscow Aeroflot Ope...
January 2007
BONESUPPORT strengthens management team for international expansion (...) is another important step in our ambition to strengthen our organisation in preparation for the impending U.S. launch of our f...
November 2006
The medical technology company BONESUPPORT AB in Lund, which develops synthetic, injectable ceramic bone substitute, has received SEK 135 million (approx. USD 19 mios) from a new share issue. The new ...
September 2006
Participation in a new Institutionnal round of financing for a portfolio Medical company.
July 2006
Blue Oak Capital will be the exclusive distributor of Stanford Group Company's institutional research to clients primarily in Europe and Asia through its international sales force. For the complete ...
March 2006
Vencorp increased its participation in a Alternative Asset Management Company in London (UK).
December 2005
Sweden, Malmö: Vencorp Senior Partners signed the definitive Share Purchase Agreement with the founders of Bone Support and Ultrazonix, to acquire a stake in these two companies. Vencorp will manage t...
November 2005
London: Vencorp consolidated its position, participating to the B round financing of BlueOak Capital, an independent London based financial research company regulated by the FSA.
November 2005
Lisbon: Vencorp officialy received the final authorisation of the regulatory Body (CMVM) to establish a VC firm in Portugal.
August 2005
Sweden: Vencorp Partners signed a MoU outlining the terms of a forthcoming investment in two Swedish companies through its European regulated vehicle, Vencorp Sicar. Bone Support is dedicated to the d...
Mai 2005
Luxembourg: Vencorp established its inaugural European Fund for Institutional investors based around the theme of Ageing Population.
